cannabis Archives - Page 2 of 2

Developments

Zenabis in $25-million of additional debt financing; extension and partial conversion of notes

Zenabis Global (TSX:ZENA) signed definitive documentation for $25-million of new senior secured debt financing from R.C. Morris Capital Management. The financing involved amending and restating the debenture...

August 21, 2019

Developments

GMP sees Zenabis among top 5 cannabis producers in Canada

In a new report, GMP Securities analyst Justin Keywood gives high marks to Zenabis Global’s (TSX:ZENA) strategy for becoming a leading cannabis producer in Canada. “We see Zenabis as becoming a top-five Canadian...

August 16, 2019

Developments

Zenabis increases licensed capacity by more than 40% with substantial completion of Zenabis Atholville

Zenabis Global (TSX:ZENA) announced the licensing of Phase 2C – Part 1 at its Zenabis Atholville facility, adding an additional 9,800 kg of licensed annual cultivation capacity of cannabis. This licensing increases...

July 29, 2019

Developments

XPhyto receives German cannabis license for scientific cultivation and extraction

The German Federal Institute for Drugs and Medical Devices (BfArM) granted XPhyto Therapeutics’ German subsidiary, Bunker Pflanzenextrakte, a cannabis cultivation and extraction license for scientific purposes. Subject...

July 25, 2019

Developments

Zenabis outperforms cannabis design capacity by 41% in June

Zenabis Global (TSX:ZENA) reported that its cultivation output in June 2019 was 756 kg of dried cannabis, which represents a 40.8% outperformance relative to design capacity, or a performance ratio of 40.8%. June 2019...

July 24, 2019

Developments

Zenabis arranges $10-million of non-dilutive financing in supply pact with Starseed Medicinal

Zenabis Global (TSX:ZENA) entered into an agreement whereby Starseed Medicinal would advance $10-million to Zenabis in September 2019 in return for dried cannabis flower and trim from Zenabis. Under the accord, Zenabis...

July 22, 2019

Developments

GMP adds Zenabis Global to Best Ideas list

GMP Securities added Zenabis Global (TSX:ZENA) to its Best Ideas list, saying its sees the company becoming a top five Canadian licensed producer of cannabis but with a valuation well below most of its peers. Analyst...

July 10, 2019

Executive Moves

Canopy Growth’s medical division names Dr. Marcel Bonn-Miller as global clinical scientific director

Spectrum Therapeutics, the medical division of Canopy Growth (TSX:WEED; NYSE:CGC) appointed Dr. Marcel Bonn-Miller as global clinical scientific director.

June 5, 2019

Tag - cannabis

Zenabis in $25-million of additional debt financing; extension and partial conversion of notes

GMP sees Zenabis among top 5 cannabis producers in Canada

Zenabis increases licensed capacity by more than 40% with substantial completion of Zenabis Atholville

XPhyto receives German cannabis license for scientific cultivation and extraction

Zenabis outperforms cannabis design capacity by 41% in June

Zenabis arranges $10-million of non-dilutive financing in supply pact with Starseed Medicinal

GMP adds Zenabis Global to Best Ideas list

Canopy Growth’s medical division names Dr. Marcel Bonn-Miller as global clinical scientific director

General

More